Belén Navarro

631 total citations
33 papers, 260 citations indexed

About

Belén Navarro is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Belén Navarro has authored 33 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 8 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Belén Navarro's work include Inflammatory Bowel Disease (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Microscopic Colitis (5 papers). Belén Navarro is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Microscopic Colitis (5 papers). Belén Navarro collaborates with scholars based in Spain, Chile and Italy. Belén Navarro's co-authors include Rafael Forés, Isabel Krsnik, Guiomar Bautista, C Regidor, Isabel Sanjuán, M Rico, Pilar Nos, Emilio Ojeda, José A. García‐Marco and Isabel Millán and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Belén Navarro

32 papers receiving 254 citations

Peers

Countries citing papers authored by Belén Navarro

Since Specialization

Citations

This map shows the geographic impact of Belén Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belén Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belén Navarro more than expected).

Fields of papers citing papers by Belén Navarro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belén Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belén Navarro. The network helps show where Belén Navarro may publish in the future.

Co-authorship network of co-authors of Belén Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of Belén Navarro. A scholar is included among the top collaborators of Belén Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belén Navarro. Belén Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	¹⁸ F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study 2024 ·Expert Review of Hematology ·Raúl Córdoba, Joaquín Sánchez‐García, Eva Domingo‐Doménech, Javier López‐Jiménez, Antonio Martı́nez, Cecilia Carpio, (unknown), (unknown), Sonia González de Villambrosía, José Codina, Belén Navarro, Guillermo Rodríguez‐Domínguez, (unknown), (unknown), Alejandro Martı́n	0
2	Peripheral T‐cell lymphoma with a T follicular‐helper phenotype: A different entity? Results of the Spanish Real‐T study 2023 ·British Journal of Haematology ·Alejandro Martı́n, Socorro Marıá Rodríguez-Pinilla, Eva Domingo‐Doménech, Fina Climent, Joaquín Sánchez‐García, Javier López Jiménez, (unknown), Josep Castellví, (unknown), Sonia González de Villambrosía, José Codina, Belén Navarro, Guillermo Rodríguez‐Domínguez, Juan José Borrero Martín, Máximo Fraga, (unknown), (unknown), Raúl Córdoba	3
3	Rehabilitación cardiorrespiratoria en hipertensión pulmonar: experiencia en un centro de referencia 2022 ·(unknown), (unknown), (unknown), (unknown), (unknown), Belén Navarro, Luis E. Gómez, (unknown)	1
4	Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non‐Hodgkin B‐cell lymphomas 2020 ·European Journal Of Haematology ·Juan‐Manuel Sancho, Belén Navarro, (unknown), Jaime Pérez de Oteyza, (unknown), Marco Bregni, (unknown), (unknown), (unknown), (unknown), Pier Luigi Zinzani	5
5	Non-guided self-learning program for high-proficiency optical diagnosis of diminutive and small colorectal lesions: A single-endoscopist pilot study 2019 ·World Journal of Gastroenterology ·Marco Bustamante, (unknown), (unknown), Belén Navarro, (unknown), (unknown), Marta Ponce, Lídia Argüello, Vicente Pons	1
6	Periendoscopic management of antiplatelet therapy: Prospective evaluation of adherence to guidelines 2019 ·Gastroenterología y Hepatología ·(unknown), (unknown), (unknown), (unknown), Belén Navarro, Marta Ponce, Vicente Pons, Lídia Argüello, Marco Bustamante	1
7	A Web-Based Telemanagement System for Patients With Complex Inflammatory Bowel Disease: Protocol for a Randomized Controlled Clinical Trial 2018 ·JMIR Research Protocols ·Mariam Aguas, Javier del Hoyo, Raquel Faubel, (unknown), (unknown), Guillermo Bastida, Belén Navarro, (unknown), Bernardo Valdivieso, (unknown), Pilar Nos	6
8	Infarto agudo de miocardio en paciente con diagnóstico reciente de enfermedad de Crohn 2018 ·Gastroenterología y Hepatología ·Belén Navarro, (unknown), (unknown), Marisa Iborra	1
9	P301 Effects of telemonitoring on safety and health care costs with a web platform (TECCU) in complex IBD patients: A randomised controlled trial 2018 ·Journal of Crohn s and Colitis ·Mariam Aguas, Javier del Hoyo, Raquel Faubel, (unknown), (unknown), Guillermo Bastida, Belén Navarro, (unknown), (unknown), Bernardo Valdivieso, (unknown), Pilar Nos	1
10	Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice 2017 ·Inflammatory Bowel Diseases ·(unknown), Virginia Bosó, Belén Navarro, (unknown), Guillermo Bastida, Belén Beltrán, Marisa Iborra, Esteban Sáez‐González, Emilio Monte‐Boquet, José Luís Poveda-Andrés, Pilar Nos	23
11	Phosphoethanolamine addition to the Heptose I of the Lipopolysaccharide modifies the inner core structure and has an impact on the binding of Polymyxin B to the Escherichia coli outer membrane 2017 ·Archives of Biochemistry and Biophysics ·(unknown), (unknown), (unknown), Belén Navarro, Daniel Aguayo	23
12	P205 A telemanagement system web in patients with complex inflammatory bowel disease: design and implementation of a randomized clinical trial 2017 ·Journal of Crohn s and Colitis ·Mariam Aguas, Javier del Hoyo, (unknown), Raquel Faubel, (unknown), Belén Navarro, Guillermo Bastida, Bernardo Valdivieso, Pilar Nos	1
13	P459. Risk of relapse after azathioprine discontinuation in inflammatory bowel disease patients in maintained remission 2016 ·Journal of Crohn s and Colitis ·Marisa Iborra, Belén Navarro, Xavier Cortés, Marta Maia Boscá-Watts, Tomás Posadas, (unknown), (unknown), Belén Beltrán, Pilar Nos	1
14	Association of DDX58 177 C > T polymorphism with decreased risk of Epstein–Barr virus-related nodular sclerosis classical Hodgkin lymphoma 2016 ·Leukemia & lymphoma ·Paloma Martín, (unknown), María José Coronado, Isabel Krsnik, Mariano Provencio, Belén Navarro, Manuela Moraru, Carmen Bellas, Carlos Vilches, Natalia Gómez‐Lozano	3
15	Theoretical and Experimental Insights into Lipopolysaccharides-Polymyxin B Interactions Using Genetically Modified Enterobacterial Strains 2015 ·Biophysical Journal ·Daniel Aguayo, (unknown), (unknown), (unknown), Belén Navarro, Nicolas Dos Santos Pacheco, (unknown)	1
16	HLA Allele E01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A01/02 2015 ·PLoS ONE* ·Paloma Martín, Isabel Krsnik, Belén Navarro, Mariano Provencio, Juan F. Garcı́a, Carmen Bellas, Carlos Vilches, Natalia Gómez‐Lozano	9
17	Immunohistochemical and Molecular Characteristics with Prognostic Significance in Diffuse Large B-Cell Lymphoma 2014 ·PLoS ONE ·Carmen Bellas, (unknown), (unknown), (unknown), Víctor Abraira, Belén Navarro, Mariano Provencio, Paloma Martín	26
18	Vascular Endothelial Growth Factor A (VEGFA) Gene Polymorphisms Have an Impact on Survival in a Subgroup of Indolent Patients with Chronic Lymphocytic Leukemia 2014 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Belén Navarro, Isabel Millán, (unknown), Rosa Collado, Pedro Sánchez‐Godoy, Félix Carbonell, José A. García-Vela, José A. García‐Marco, Natalia Gómez‐Lozano	9
19	Paroxysmal Nocturnal Hemoglobinuria and Magnetic Resonance Imaging 2013 ·Blood ·Miguel Pastrana, (unknown), Emilio Ojeda, Rafael Forés, (unknown), (unknown), Daniel Morillo, Guiomar Bautista, Belén Navarro, Isabel Krsnik, (unknown), Santiago Gil, C Regidor, José Luis Bueno, José A. García‐Marco, José Rafael Cabrera	1
20	Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults 2009 ·Cytotherapy ·Rosa M. Gonzalo‐Daganzo, C Regidor, Trinidad Martín-Donaire, M Rico, Guiomar Bautista, Isabel Krsnik, Rafael Forés, Emilio Ojeda, Isabel Sanjuán, José A. García‐Marco, Belén Navarro, Santiago Gil, (unknown), (unknown), Yolanda Gutiérrez, (unknown), (unknown), Isabel Millán, Rafael Cabrera, Manuel N. Fernández	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact